NeuroTronik Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $238K
Latest Deal Amount
  • Investors
  • 6

NeuroTronik General Information

Description

Developer of neurostimulation therapeutic devices designed to treat acute heart failure syndrome. The company's device is a cardiac autonomic nerve stimulation delivered via a NeuroCathete, placed temporarily in a vein just above the heart, in combination with a NeuroModulator, positioned bedside, which results in enhanced cardiac output free of elevated heart rate, enabling physicians to treat patients suffering from acute heart failure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
  • 4021 Stirrup Creek Drive
  • Suite 210
  • Durham, NC 27703
  • United States
+1 (919) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroTronik Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 10-Feb-2020 $238K 000.00 Completed Product Development
2. Early Stage VC 18-Apr-2017 000.00 000.00 000.00 Completed Product Development
1. Early Stage VC (Series A) 13-Jun-2013 $13.1M $13.1M 000.00 Completed Startup
To view NeuroTronik’s complete valuation and funding history, request access »

NeuroTronik Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view NeuroTronik’s complete cap table history, request access »

NeuroTronik Executive Team (3)

Name Title Board Seat Contact Info
Frederick McCoy Jr. Chief Executive Officer, Board Member & President
Steve Masson Chief Technology Officer & Vice President, Research & Development
William Starling Jr. Co-Founder
To view NeuroTronik’s complete executive team members history, request access »

NeuroTronik Board Members (5)

Name Representing Role Since
Douglas Reed MD Hatteras Venture Partners Board Member 000 0000
Frederick McCoy Jr. NeuroTronik Chief Executive Officer, Board Member & President 000 0000
Jeff Terrell Hatteras Venture Partners Board Observer 000 0000
Mudit Jain Ph.D Synergy Life Science Partners Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

NeuroTronik Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroTronik Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boston Scientific Ventures Corporate Venture Capital Minority 000 0000 000000 0
Sovereign's Capital PE/Buyout Minority 000 0000 000000 0
Hatteras Venture Partners Venture Capital Minority 000 0000 000000 0
Lord Baltimore Investment Partners Family Office Minority 000 0000 000000 0
Mountain Group Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »